RecruitingNCT06208007

Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF


Sponsor

University Medical Center Goettingen

Enrollment

150 participants

Start Date

Feb 23, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Patients at risk for developing heart failure with preserved ejection fraction (HFpEF) will undergo a structured clinical assessment, transthoracic echocardiography and pulse-wave analysis to investigate the association of arterial stiffening and the development of cardiac diastolic dysfuntion and HFpEF.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study investigates whether stiff arteries are an early warning sign of a type of heart failure where the heart pumps normally but cannot relax properly (called HFpEF or diastolic dysfunction). Researchers will use imaging tests to study the link between arterial stiffness and this condition. **You may be eligible if...** - You are over 60, OR have high blood pressure, diabetes, atrial fibrillation, chronic kidney disease, or obesity (BMI ≥ 30) - You have been referred for cardiac imaging **You may NOT be eligible if...** - Your heart's pumping function is significantly reduced (ejection fraction below 50%) - You have significant heart valve disease or prior valve surgery - You have serious respiratory conditions that affect heart imaging Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Universitätsmedizin Göttingen

Göttingen, Lower Saxony, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06208007


Related Trials